Avalyn Pharma Inc. (Nasdaq: AVLN), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. ATS 2026 keynote series topics include vaccines, legal ...

NEW YORK, NY – (Feb. 08, 2023) – The American Thoracic Society, together with six sites across the U.S., is launching the ATS ICU Pause Initiative to educate health care providers about patient safety ...

The American Thoracic Society (ATS) traces its beginnings to 1905. ATS is a non-profit international, professional scientific society formed to education, advance research and advocate for respiratory ...

Patient org gives researcher awards, presents poster, hosts sessions and exhibits at prestigious lung meeting There is ...

With its link to more than $1 trillion in welfare losses globally in 2023, tuberculosis is described as “a macroeconomic ...

NEW YORK, NY – Oct. 02, 2025 – In an effort to ensure its journals’ long-term success, the American Thoracic Society has partnered with Oxford University Press (OUP), a leading nonprofit publisher.

To reduce the global burden of respiratory diseases and tackle inequalities, the Forum of International Respiratory Studies and the American Thoracic Society suggested improving access to preventive ...

Bambusa Therapeutics, Inc. (Bambusa Therapeutics), a clinical-stage biotechnology company advancing next-generation, long-acting bispecific antibodies for immunology and inflammation, today announced ...

As cities brace for a confluence of flu, COVID-19, pneumonia, and RSV infections this fall, the American Thoracic Society announced that five new health systems have partnered with the Society to ...

Le Roy and Rosie Torres to address pulmonologists and researchers at Sunday’s Terrorism and Inhalation Disasters ...